News | March 15, 2023
LifeSigns raises Pre-Series A
A funding to expand operations and provide better patient care
A funding to expand operations and provide better patient care
The company's consolidated revenues for the quarter grew 36% to Rs. 3,020 crore on the back of robust performance across all its three businesses
The company will not receive any proceeds from the offer as all of it will go to the promoter selling shareholder.
This DSIR recognition for company's in-house R&D Unit make it eligible for receiving funds for R&D purpose from various government departments and agencies
Krishna Institute of Medical Sciences to consider raising Rs. 300 crores
Miravo to remain a Canadian controlled and operated company following closing of the transaction
Allam was serving recently as the CEO at Public Investment Fund
The funds raised through the issue will be utilised to meet the working capital requirements to fund the company's expansion plans, entering new geographies and for general corporate purposes
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
Acquisition expands Merck’s growing hematology portfolio
Subscribe To Our Newsletter & Stay Updated
